Tyme Technologies, Inc.
Tyme Technologies, Inc. is a clinical-stage biotechnology company developing cancer therapeutics that are intended to be broadly effective across tumor types while having a low toxicity profile.
Last Closing Price
March 1, 2018
Evercore, Stifel, Canaccord
To view the prospectus for Tyme Technologies, Inc., or any offering listed on ClickIPO,
download the ClickIPO app...
or a prospectus can be requested from G. Price at
ClickIPO Securities, LLC P. O. Box 21154, Mesa, AZ 85277